Jpmorgan Chase & CO Biogen Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Biogen Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,102,469 shares of BIIB stock, worth $747 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,102,469

Previous 4,714,957 8.22%

Holding current value

$747 Million

Previous $1.09 Billion 9.51%

% of portfolio

0.08%

Previous 0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$189.07 - $236.8 $73.3 Million - $91.8 Million	387,512 Added 8.22%	5,102,469 $989 Million
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $3.86 Million - $4.8 Million	20,263 Added 0.43%	4,714,957 $1.09 Billion
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $67.1 Million - $84.8 Million	-316,625 Reduced 6.32%	4,694,694 $1.01 Billion
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $5.69 Million - $6.85 Million	25,567 Added 0.51%	5,011,319 $1.3 Billion
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $130 Million - $147 Million	514,565 Added 11.51%	4,985,752 $1.28 Billion
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $99.7 Million - $115 Million	362,324 Added 8.82%	4,471,187 $1.27 Billion
Q1 2023 May 18, 2023	BUY	$256.56 - $292.34 $17.4 Million - $19.8 Million	67,783 Added 1.68%	4,108,863 $1.14 Billion
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $454 Million - $518 Million	1,770,773 Added 78.0%	4,041,080 $1.12 Billion
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $42 Million - $51 Million	166,390 Added 7.91%	2,270,307 $629 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $25.1 Million - $34.6 Million	128,827 Added 6.52%	2,103,917 $562 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $37.6 Million - $44.7 Million	-200,467 Reduced 9.21%	1,975,090 $403 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $457 Million - $576 Million	-2,360,923 Reduced 52.04%	2,175,557 $458 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $239 Million - $308 Million	-1,068,817 Reduced 19.07%	4,536,480 $1.09 Billion
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $1.59 Billion - $2.07 Billion	5,605,297 New	5,605,297 $1.59 Billion

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Biogen Inc. Transaction History